Timothy J. Korzinski

Timothy J. Korzinski

Auto-generated profile, based on publicly available information

Timothy J. Korzinski

Cardiovascular Engineering, Inc, Needham, MA (D.J.H.-S., T.J.K., G.F.M.).

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2026 in Hypertension
Verified
Journal Article
Closed access
TKTimothy J. Korzinski
Timothy J. Korzinski
BPBrenton Prescott
Brenton Prescott
DHDavid J. Hamel-Sellman
David J. Hamel-Sellman
VXVanessa Xanthakis
Vanessa Xanthakis
LCLeroy L. Cooper
Leroy L. Cooper
GMGary F. Mitchell
Gary F. Mitchell
BACKGROUND: Arterial pressure waveform shape conveys information regarding interactions between the left ventricle and aorta that could provide an estimate of biological heart age and cardiovascular disease (CVD) risk. METHODS: Artificial intelligence heart age (AI-HA) was estimated by averaging results from 2 convolutional neural networks trained to predict mitral annulus tissue Doppler e’ and s’ peak velocities using an uncalibrated arterial tonometry or photoplethysmography waveform as input. Models were developed using FHS (Framingham Heart Study) participant pressure waveforms and echocardiographic measurements (N=6916 participants, 38 174 waveforms, 56% women, mean age 61±12). We validated AI-HA using Cox modeling in an FHS holdout set of baseline radial waveforms (N=7018, 54% women, age 50±16 years) and in UK Biobank participants (N=67 986, 53% women, age 57±8 years). RESULTS: In FHS (up to 10 years of follow-up, 148 heart failure [HF] and 331 CVD events), using models that adjusted for PREVENT (AHA Predicting Risk of CVD Events) risk factors, AI-HA was associated with incident HF (hazard ratio, 2.09 [CI, 1.64–2.68]; continuous net reclassification, 0.22 [CI, 0.13–0.30]) and CVD (hazard ratio, 1.52 [CI, 1.28–1.81]; continuous net reclassification, 0.13 [CI, 0.07–0.20]). In UK Biobank (up to 10 years of follow-up, 1408 HF and 2709 CVD events), AI-HA was associated with incident HF (hazard ratio, 1.23 [CI, 1.13–1.33]; continuous net reclassification, 0.09 [CI, 0.06–0.12]) and CVD (hazard ratio, 1.22 [CI, 1.15–1.30]; continuous net reclassification, 0.08 [CI, 0.06–0.09]). CONCLUSIONS: AI-HA is a novel and accessible measure of left ventricle function and HF risk in community-based samples.

16 December 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
DHDavid J. Hamel‐Sellman
David J. Hamel‐Sellman
BPBrenton Prescott
Brenton Prescott
TKTimothy J. Korzinski
Timothy J. Korzinski
VXVanessa Xanthakis
Vanessa Xanthakis
LCLeroy L. Cooper
Leroy L. Cooper
GMGary F. Mitchell
Gary F. Mitchell
Background: Aortic stiffening increases pulsatile power transmission into the microvasculature, resulting in blunted microvascular reactivity, which can impair postprandial nutrient processing and glucose homeostasis. Cardiometabolic disease (CMD) contributes to aortic stiffening and risk for major cardiovascular disease events. Our goal was to assess potential bidirectional relations of aortic stiffness with CMD progression. Methods: Relations of artificial intelligence vascular age (AI‐VA), a measure of aortic stiffness, with new‐onset hypertension, diabetes, obesity, and lipid abnormalities were assessed in 7188 Framingham Heart Study (FHS) participants by using Cox proportional hazards regression. Short‐term bidirectional relations of AI‐VA with key continuous cardiometabolic measures were assessed by using autoregressive cross‐lagged panel models at 2 visits 6 years apart. Progression to CMD and cardiovascular disease states was visualized using multistate transition analysis. Results: In models adjusted for standard vascular risk factors, accelerated AI‐VA was associated with elevated risk for incident hypertension (hazard ratio [HR], 1.44 [95% CI, 1.24–1.61]), diabetes (HR 1.29 [95% CI, 1.07–1.56]), lipid abnormalities (HR 1.13 [95% CI, 1.00–1.28]), and obesity (HR 1.23 [95% CI, 1.06–1.42]). Autoregressive cross‐lagged panel models demonstrated bidirectional relations between AI‐VA and fasting blood glucose, triglycerides, and mean arterial pressure consistent with a self‐reinforcing cycle of CMD progression. Multistate transition analysis demonstrated that most cardiovascular disease events (70%) occurred in participants who had developed at least 2 CMD states. Conclusions: In our community‐based sample with repeated measures, AI‐VA, a measure of aortic stiffness, had bidirectional relations with continuous cardiometabolic measures and incident CMD, highlighting the potential utility of AI‐VA as a novel screening tool for CMD risk.

1 November 2025 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
TKTimothy J. Korzinski
Timothy J. Korzinski
CHCelestin Hategeka
Celestin Hategeka
BPBrenton Prescott
Brenton Prescott
DHDavid J. Hamel-Sellman
David J. Hamel-Sellman
VXVanessa Xanthakis
Vanessa Xanthakis
Emelia J. BenjaminEmelia J. Benjamin
Emelia J. Benjamin

1 November 2026 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
LCLeroy L. Cooper
Leroy L. Cooper
ABAyantika Banerjee
Ayantika Banerjee
ABAlexa S. Beiser
Alexa S. Beiser
SCSokratis Charisis
Sokratis Charisis
DHDavid J. Hamel-Sellman
David J. Hamel-Sellman
GMGary F. Mitchell
Gary F. Mitchell
BACKGROUND: Accelerated vascular aging, assessed as artificial intelligence–based vascular age (AIVA), is associated with small vessel disease that may impact brain structure and neuropsychological function. METHODS: In a cross-section of Framingham Heart Study participants, AIVA was estimated using a validated convolutional neural network trained to predict carotid-femoral pulse wave velocity from a normalized pressure waveform. Brain structure was assessed using magnetic resonance imaging with diffusion tensor imaging, and neuropsychological function was assessed using a standardized test battery. Analyses included magnetic resonance imaging (N=2313) and neuropsychological (N=3001) samples. We used multivariable linear and logistic regression to relate AIVA to brain structural and neuropsychological functional measures. RESULTS: The mean±SD age across participants was 62±11 years; 56% were women. In multivariable models, higher AIVA was associated with worse markers of cerebral small vessel disease (mean white matter free water: β [per SD], 0.09 [95% CI, 0.04–0.14]; P <0.001; peak width of skeletonized mean diffusivity: β , 0.05 [95% CI, 0.00–0.10]; P =0.045; white matter hyperintensity volume: β , 0.08 [95% CI, 0.03–0.12]; P <0.001) and higher odds of cerebrovascular injury (presence of extensive white matter hyperintensities: odds ratio [per SD], 1.22 [95% CI, 1.02–1.47]; P =0.03; presence of brain infarcts: odds ratio, 1.44 [95% CI, 1.02–2.04]; P =0.04). In addition, higher AIVA was associated with worse performance on Trails B-A ( β , −0.05 [95% CI, −0.10 to −0.01]; P =0.03), similarities ( β , −0.06 [95% CI, −0.11 to −0.01]; P =0.02), and global cognition ( β , − 0.07 [95% CI, −0.12 to −0.03]; P =0.002) and higher odds of prevalent depressive symptoms (odds ratio, 1.24 [95% CI, 1.08–1.41]; P =0.002) and high Center for Epidemiologic Studies Depression Scale score (odds ratio, 1.20 [95% CI, 1.00–1.44]; P =0.047). Vascular brain injury markers partially mediated the associations of AIVA with global cognition score and presence of depressive symptoms. CONCLUSIONS: Peripheral pressure waveform AIVA may be a novel, noninvasive indicator of subclinical vascular brain injury and neuropsychological function.